• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


6.2500 USD 0.1600 2.50%

As of 14:20:38 ET on 10/20/2014.

Snapshot for SCYNEXIS Inc (SCYX)

Open: 6.0200 Day's Range: 5.7500 - 6.2500 Volume: 18,260
Previous Close: 6.4100 52wk Range: 5.1020 - 10.0000 1-Yr Rtn: -

Stock Chart for SCYX

No chart data available.
  • SCYX:US 6.2400
  • 1D
  • 1M
  • 1Y
Interactive SCYX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SCYX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.8950
Est. PEG Ratio -
Market Cap (M USD) 53.14
Shares Outstanding (M) 8.50
30 Day Average Volume 9,402
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SCYX

No data available

Company Profile & Key Executives for SCYX

SCYNEXIS, Inc. provides pharmaceutical products. The Company discovers, develops, and distributes intravenous drug for the treatment of serious and life-threatening invasive fungal infections in humans. SCYNEXIS serves customers in the United States.

Yves J RibeillPresident/CEOCharles F Osborne Jr "Chuck"Chief Financial Officer
Eileen C PruetteSecy/General Counsel
More Company Profile & Key Executives for SCYX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil